Scientific momentum is so strong in the cannabis industry that even our straight-arrow federal government wants in. While the Drug Enforcement Administration still clings to the claim that the plant has no medical value, the National Institutes of Health funded 49 projects examining the therapeutic properties of cannabinoids last year. The NIH is also ramping up production at the University of Mississippi’s only federally funded marijuana farm, the exclusive supplier for Federal Drug Administration-approved studies. Here are some of the trailblazers to watch:
Multidisciplinary Association for Psychedelic Studies
The California-based nonprofit made history when it announced plans to study cannabis as a treatment for post-traumatic stress disorder in U.S. veterans. Its clinical trial investigating “smoked botanical marijuana” was the first to receive both FDA and DEA approval.
The British company’s natural cannabis-derived mouth spray, Nabiximols, was approved in the United Kingdom in 2010 to treat multiple sclerosis and is
... read more at: https://www.good.is/articles/issue-38-cannabis-lab-scientific-research